Press release

Verana Health Expands Into New Therapeutic Area with American Academy of Neurology Partnership

0
Sponsored by Businesswire

Verana Health and the American Academy of Neurology (AAN) have announced
a landmark partnership focused on accelerating medical research in
neurology using real-world evidence generated with information from the Axon
Registry®
. This exclusive partnership reflects Verana
Health’s commitment to partnering with medical associations across
therapeutic areas to advance patient health with data insights. With
this collaboration agreement Verana Health continues to assemble the
largest clinical databases in medicine, beginning with the company’s
partnership with the American Academy of Ophthalmology.

“We are entering an exciting era where data-driven medicine is improving
the quality of the care we’re providing and giving us clues about which
therapies work best, and how we may be able to better predict and
prevent disease,” said Ralph L. Sacco, MD, MS, FAHA, FAAN, president of
the American Academy of Neurology, the world’s largest association of
neurologists with 36,000 members. “By collaborating with Verana Health,
we will be able to accelerate research projects using our growing Axon
Registry to benefit and provide hope for our patients.”

The Axon Registry is a rapidly growing neurology data set including
clinical data from 1.5 million unique patients and 5 million patient
visits. The collaboration between Verana Health and the AAN will
facilitate the development and delivery of de-identified clinical data
solutions for use by the Axon Registry, its participants, industry
partners, and the broader neurologic community – aiming to improve
treatments and discover cures for the one in six people affected by
neurologic disease. Using de-identified clinical data provides a
meaningful opportunity to analyze which therapies are producing the
greatest patient benefit.

“Clinical data registries, such as the Axon Registry, enable us to
understand patient needs and outcomes at scale,” said Miki Kapoor,
president and CEO of Verana Health. “We look forward to working closely
with the AAN and the neurologic community to identify the most
meaningful opportunities to enhance patient care and accelerate health
care innovation through the magnitude of information found in the Axon
Registry.”

Learn more about the Axon
Registry
and review Frequently
Asked Questions
about the AAN and Verana Health collaboration. To
learn more about Verana’s clinical data solutions, contact insights@veranahealth.com
or visit Verana Booth #1602 at the AAN Annual Meeting 2019 in
Philadelphia.

About Verana Health

Verana Health is a technology company assembling the largest clinical
databases in medicine. Verana Health utilizes this real-world data to
derive clinical and business insights for physicians and life science
companies through its regulatory-grade data platform. By activating this
vast amount of data, Verana Health can learn from the collective
experience of millions of individual patients to empower physicians and
accelerate research for patients. Learn more at veranahealth.com.